Literature DB >> 9410879

Pulse treatment of interphasic HeLa cells with nanomolar doses of docetaxel affects centrosome organization and leads to catastrophic exit of mitosis.

A Paoletti1, N Giocanti, V Favaudon, M Bornens.   

Abstract

In order to investigate the role of centrosome duplication in mitotic spindle morphogenesis, we designed a 1 hour pulse treatment protocol on synchronized HeLa cells with nanomolar doses of taxoids that might impair centrosome biogenesis but would allow the recovery of normal microtubule (Mt) dynamics before mitosis. We were prompted to use this approach as docetaxel (DOC; taxotereTM), a taxoid known to promote Mt polymerization, was shown to be more cytotoxic when applied during S phase. We show that pulse drug exposure is most efficient in late S and in G2 and results in a marked disorganization of the centrosome in G2, the pericentriolar material (PCM) being dissociated from centrioles. Separation of centrosomes at the G2-M transition is also impaired and mitotic spindle morphogenesis is grossly abnormal: although in most spindles chromosomes align in a metaphase plate, the two centrosomes stay most often unseparated at one pole and most of the NuMA protein accumulates at the other. Interestingly, we find that the centrosomes' ability to duplicate is not abolished as they are still able to trigger parthenogenetic development of frog eggs. Despite spindle asymmetry, the progression through mitosis is not blocked. This results in a catastrophic exit from mitosis, each mitotic cell generating several micronucleated cells linked together by multiple midbodies. Lack of mitotic block appears therefore as the prime cause of cell lethality. These experiments suggest that NuMA redistribution at the onset of mitosis depends upon the correct redistribution of PCM between centriole pairs. They also indicate that the presence of aberrant spindle poles does not alert the surveillance mechanism controlling the exit of mitosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9410879     DOI: 10.1242/jcs.110.19.2403

Source DB:  PubMed          Journal:  J Cell Sci        ISSN: 0021-9533            Impact factor:   5.285


  14 in total

Review 1.  Mitosis as an anti-cancer drug target.

Authors:  Anna-Leena Salmela; Marko J Kallio
Journal:  Chromosoma       Date:  2013-06-18       Impact factor: 4.316

2.  Low-dose laulimalide represents a novel molecular probe for investigating microtubule organization.

Authors:  Melissa J Bennett; Gordon K Chan; J B Rattner; David C Schriemer
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

Review 3.  Mitotic spindle multipolarity without centrosome amplification.

Authors:  Helder Maiato; Elsa Logarinho
Journal:  Nat Cell Biol       Date:  2014-05       Impact factor: 28.824

4.  The PIM1 kinase is a critical component of a survival pathway activated by docetaxel and promotes survival of docetaxel-treated prostate cancer cells.

Authors:  Marina Zemskova; Eva Sahakian; Svetlana Bashkirova; Michael Lilly
Journal:  J Biol Chem       Date:  2008-04-21       Impact factor: 5.157

5.  Modulation of nanoparticle uptake, intracellular distribution, and retention with docetaxel to enhance radiotherapy.

Authors:  Aaron Henry Bannister; Kyle Bromma; Wonmo Sung; Mesa Monica; Leah Cicon; Perry Howard; Robert L Chow; Jan Schuemann; Devika Basnagge Chithrani
Journal:  Br J Radiol       Date:  2019-12-12       Impact factor: 3.039

6.  Low-dose paclitaxel synergizes with oncolytic adenoviruses via mitotic slippage and apoptosis in ovarian cancer.

Authors:  C K Ingemarsdotter; S K Baird; C M Connell; D Öberg; G Halldén; I A McNeish
Journal:  Oncogene       Date:  2010-08-23       Impact factor: 9.867

7.  Inactivation of wild-type p53 by a dominant negative mutant renders MCF-7 cells resistant to tubulin-binding agent cytotoxicity.

Authors:  C M Galmarini; N Falette; E Tabone; C Levrat; R Britten; N Voorzanger-Rousselot; O Roesch-Gateau; A Vanier-Viornery; A Puisieux; C Dumontet
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

8.  Differential cytotoxicity induced by the Titanium(IV)Salan complex Tc52 in G2-phase independent of DNA damage.

Authors:  Theresa Pesch; Harald Schuhwerk; Philippe Wyrsch; Timo Immel; Wilhelm Dirks; Alexander Bürkle; Thomas Huhn; Sascha Beneke
Journal:  BMC Cancer       Date:  2016-07-13       Impact factor: 4.430

9.  Centriole disassembly in vivo and its effect on centrosome structure and function in vertebrate cells.

Authors:  Y Bobinnec; A Khodjakov; L M Mir; C L Rieder; B Eddé; M Bornens
Journal:  J Cell Biol       Date:  1998-12-14       Impact factor: 10.539

10.  Laulimalide induces dose-dependent modulation of microtubule behaviour in the C. elegans embryo.

Authors:  Megha Bajaj; Martin Srayko
Journal:  PLoS One       Date:  2013-08-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.